Cerutti Elisabetta, D'Arcangelo Francesca, Becchetti Chiara, Cilla Marta, Cossiga Valentina, Guarino Maria, Invernizzi Federica, Lapenna Lucia, Lavezzo Bruna, Marra Fabio, Merli Manuela, Morelli Maria Cristina, Toniutto Pierluigi, Burra Patrizia, Zanetto Alberto
Department of Anesthesia, Transplant and Surgical Intensive Care, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Gastroenterology and Multivisceral Transplant Unit, Padua University Hospital, Padua, Italy.
Dig Liver Dis. 2025 Feb;57(2):355-361. doi: 10.1016/j.dld.2024.08.002. Epub 2024 Aug 19.
Acute-on-chronic liver failure (ACLF) is a severe clinical syndrome characterized by acute liver decompensation in patients with chronic liver disease, marked by systemic inflammation and systemic organ failure. In this review, we discussed sex-related disparities in the incidence, prognosis, and access to liver transplantation (LT) for patients with ACLF, particularly during Intensive Care Unit (ICU) management. Some studies have suggested that ACLF is more prevalent among male patients admitted to the ICU, and they have higher mortality rates than females. Available prognostic scores, such as CLIF-C or TAM-score, lack sex-specific adjustments. Sarcopenia seems to enhance the accuracy of these scores though this is observed only in male individuals. LT is the only effective treatment for patients with ACLF grade 2-3 who do not respond to medical therapies. Sex-related disparities occur in both access to LT and post-transplant outcomes, although the influence of sex on the prevalence, clinical course, and listing for LT in ACLF remains largely undetermined. A sex-orientated analysis of ICU outcomes in ACLF would facilitate the development of sex-orientated management strategies, thereby improving patients' outcomes.
慢加急性肝衰竭(ACLF)是一种严重的临床综合征,其特征为慢性肝病患者出现急性肝功能失代偿,以全身炎症和全身器官衰竭为显著表现。在本综述中,我们讨论了ACLF患者在发病率、预后以及肝移植(LT)可及性方面的性别差异,尤其是在重症监护病房(ICU)管理期间。一些研究表明,入住ICU的男性患者中ACLF更为普遍,且其死亡率高于女性。现有的预后评分,如CLIF-C或TAM评分,缺乏针对性别的调整。肌肉减少症似乎可提高这些评分的准确性,不过这仅在男性个体中观察到。LT是对药物治疗无反应的2-3级ACLF患者的唯一有效治疗方法。在LT的可及性和移植后结局方面均存在性别差异,尽管性别对ACLF的患病率、临床病程以及LT列入名单的影响在很大程度上仍未确定。对ACLF患者的ICU结局进行性别导向分析将有助于制定性别导向的管理策略,从而改善患者的结局。